Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Polycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Polycystic Kidney Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Polycystic Kidney ... Read More
-
Polycystic Ovarian Syndrome Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Polycystic Ovarian Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Polycystic Ovarian ... Read More
-
Allergic Rhino-Conjunctivitis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Allergic Rhino-Conjunctivitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Rhino-Conjunctivitis. Report includes an ... Read More
-
Dry (Atrophic) Macular Degeneration Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Dry (Atrophic) Macular Degeneration Clinical trials scenario. This report provides top line data relating to the clinical trials ... Read More
-
Amyloidosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Sponsor Type, and Top Countries, 2023 Update provides an overview of Amyloidosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Amyloidosis. Report includes an overview of trial numbers ... Read More
-
Global Influenza Vaccines Market, Persons Vaccinated, Key Company Analysis, Emerging Players Profile, Promising Influenza Vaccines in Clinical Development, Size, Share, Trends, Major Deals and Recent Developments - Forecast to 2030
... is projected to reach US$ 10.9 Billion by 2030. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The Centers for Disease Control and Prevention (CDC) recommends routine seasonal influenza vaccination ... Read More
-
COVID-19 Vaccines Market Size, Trends and Analysis by Disease Overview, Epidemiology, Unmet Needs and Opportunities, Therapeutic Landscape, Pipeline Assessment, Clinical Trial Strategies and Forecast to 2026
... COVID-19 market including disease overview, epidemiology, current treatment options, unmet needs and opportunities, R&D strategies, pipeline assessment, and market outlook. COVID-19 is a disease caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 ... Read More
-
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... diagnosed prevalent cases of DLBCL are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for DLBCL. Rituximab in combination with chemotherapy is the standard treatment for DLBCL in the first-line setting. ... Read More
-
Clinical Trials Support Services Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Factors such as R&D, Clinical Trials ... Read More
-
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound, ECHO), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) & Region - Global Forecast to 2028
... to 2028 The global clinical trial imaging market is projected to reach USD 1.9 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 7.8% during the forecast period. The market's expansion ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... million diagnosed prevalent cases of DN are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for DN. Among the marketed DN drugs available, most of the drugs are enzyme inhibitors, followed ... Read More
-
DNA Encoded Library: Platform and Services Market (2nd Edition), 2023-2035
... grow at compounded annual growth rate (CAGR) of 16.04% during the forecast period 2023-2035. Over the years, DNA encoded libraries have emerged as a powerful platform for drug discovery, enabling the synthesis and screening of ... Read More
-
Clinical Trial Imaging Industry Research Report 2023
... unbiased and professional imaging support. Highlights The global Clinical Trial Imaging market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and ... Read More
-
Juvenile Macular Degeneration (JMD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases of JMD are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for JMD. There are significant unmet clinical need in the JMD treatment space due to a lack of ... Read More
-
Intranasal Therapeutics and Drug Delivery Systems Market, 2022-2035
... to account for 12.2% of the global death rate, in 2030. In this context, several research initiatives are underway to identify an approach that allows effective delivery of the target medication directly into the brain. ... Read More
-
Spinal Muscular Atrophy (SMA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases of 5q SMA (types I–IV) are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for SMA. Only a handful of approved therapeutic drugs are currently available for the treatment ... Read More
-
Global Computational Biology Market Size study & Forecast, by Application (Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software), by Services (Contract, In-house), by End Use (Academics & Research, Commercial) and Regional Analysis, 2023-2030
... (Academics & Research, Commercial) and Regional Analysis, 2023-2030 Global Computational Biology Market is valued at approximately USD 6.57 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 19.50% ... Read More
-
Dyslipidemia by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2032
... Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the dyslipidemia market through 2032. Examples of key findings from this report include the following - 2022 base year sales within the dyslipidemia market ... Read More
-
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032
... the 3MM, at an AGR of 0.61%. Currently, the treatment regimen for vWD in the 3MM is mostly limited to DDAVP and coagulation factor VIII + vWF complex. There are several unmet needs in this ... Read More
-
North America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
... Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others] The North America clinical trial imaging market is expected to grow ... Read More
-
Primary Immune Deficiency (PID) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... prevalent cases are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for primary immune deficiency (PID). The marketed drugs space for PID is dominated by immunoglobulin-based therapies. R&D activity in PID ... Read More
-
South America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
... Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others] The South America clinical trial imaging market is expected to grow ... Read More
-
Clinical Trials - Precision and Personalized Medicine
... interchangeably as they refer to similar types of treatment. They both define the stratification of patients within a disease segment using their genomic and phenotypic variations to find targeted therapies. This is an alternative to ... Read More
-
Site Management Organizations Market, 2021-2035
... 40% of the total investment made for the development of drug candidate is dedicated to clinical trials; this is equivalent to an expenditure of USD 78 billion annually. However, the conduct of such trials is ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the report include - Disease Landscape Disease Overview Epidemiology Overview Treatment Overview ... Read More
Research Assistance
